Modes and duration
- Full-time: 1 year
Tuition Fees (2015/16)
- £9,835 (FT)
- £23,690 (FT)
- All applicants:
- 31 July 2015
A medical degree or a minimum of an upper second-class UK Bachelor’s degree in biomedical science, or another relevant discipline, or an overseas qualification of an equivalent standard.
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of a good level of English proficiency.
English Language Requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
The processes involved in translating immunological discoveries into predictive, diagnostic and/or therapeutic applications are described in depth, using examples of successful translational studies to illustrate key aspects: the clinical question; study design and limitations. Students will also attend scientific lectures in relevant subject areas (immunology, molecular cell biology, pharmacology), gaining hands-on experience in an original research project.
Students undertake modules to the value of 180 credits.
The programme consists of five core modules (75 credits), three optional modules (45 credits), and a dissertation/report (60 credits).
- Developing Translational Research
- Masterclasses in Translational Immunobiology
- Ocular Immunology
- Research in Practice
- Translating Science into the Clinic
- Cost Benefit Analysis and Health
- Genetics and Epidemiology of Ocular Disease
- Modern Aspects of Drug Discovery
- Ocular Cell Biology
- Ocular Development in Health and Disease
- Pharmacogenomics, Adverse Drug Reactions and Biomarkers
Students will carry out an independent research project supervised by internationally recognised researchers, resulting in a dissertation of 10,000–12,000 words and an oral presentation/viva voce.
Teaching and Learning
The programme is delivered through a combination of lectures, seminars and student group presentations. Assessment is through a mixture of unseen examinations, coursework (essays, bioinformatic tasks, practicals), a major dissertation, and oral presentations.
Scholarships relevant to this department are displayed below. For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
The first cohort of students on the Translational Immunobiology MSc are due to graduate in 2015, therefore no information on graduate destinations is currently available.
This programme is of particular interest to those science graduates considering alternative career directions in addition to mainstream research. Due to the translational content, this programme offers key knowledge and skills with wider applications outside of academia for those interested in pursuing clinical trial design, governance, clinical trial management, and grants administration within relevant governmental bodies, the pharmaceutical and medical industry.
Why study this degree at UCL?
UCL is the largest centre for biomedical research in the UK – with immunobiology, immunity and infection all major specialities across the university – and offers unique opportunities to study translational immunobiology.
The UCL Institute of Ophthalmology is an international leader in translational research and clinical and industrial collaborations are in place. UCL academics who advise on aspects of research methodology involved in successful translational projects – the design of studies, applications for Ethics approval, funding applications, peer-review publications, data presentation and writing skills – will also provide case studies, presentations and seminars.
The eye is an excellent model for monitoring disease activity, responses to therapy, and clinical scoring, and is an ideal organ through which to study pathological and anatomical changes as the responses in the eye can also be used to inform on other sites in the body. The eye is also a very accessible site for delivering new therapies.
Student / staff ratios › 77 staff › 57 taught students › 112 research students
Department: Institute of Ophthalmology
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is best suited to science graduates or clinicians looking to further their career in translational research, either in academia or a pharmaceutical setting. Alternatively, the programme will be highly useful for scientists or clinicians looking to move into related areas such as clinical trials, research regulation and management.
- All applicants
For more information see our Applications page.Apply now
What are we looking for?When we assess your application we would like to learn:
- why you want to study Translational Immunobiology at graduate level
- why you want to study Translational Immunobiology at UCL
- what particularly attracts you to this programme
- how your personal, academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree